title: Cisplatin plus vinorelbine (PVn) as a salvage regimen for refractory breast cancer.
authors.affiliation: Division of Hematology/Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Box 113-6044, Beirut 1107 2802, Lebanon.
authors.forename: Aref
authors.initials: A
authors.lastname: Chehal
authors.forename: Ali
authors.initials: A
authors.lastname: Taher
authors.forename: Mazen
authors.initials: M
authors.lastname: Khalil
authors.forename: Ali
authors.initials: A
authors.lastname: Shamseddine
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000556:secondary; D002945:Cisplatin / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008875:Middle Aged; D009362:Neoplasm Metastasis; D016879:Salvage Therapy; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077235:Vinorelbine
chemical_list: D014747:Vinblastine; D002945:Cisplatin; D000077235:Vinorelbine